EP3897700 - PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 24.09.2021 Database last updated on 24.08.2024 | |
Former | The international publication has been made Status updated on 02.07.2020 | Most recent event Tooltip | 16.02.2024 | New entry: Decision on request for further processing | Applicant(s) | For all designated states Immune Design Corp. 1616 Eastlake Ave. E. Suite 310 Seattle, WA 98102 / US | [2021/43] | Inventor(s) | 01 /
BERGLUND, Peter Lars Aksel 1616 Eastlake Avenue E, Suite 310 Seattle, Washington 98102 / US | 02 /
ALBERSHARDT, Tinglan Tina 7725 Woods Estate Lane NE Olympia, Washington 98506 / US | 03 /
TER MEULEN, Jan Henrik 3842 W. Mercer Way Mercer Island, Washington 98040 / US | 04 /
LELEUX, Jardin Alexandra 1616 Eastlake Avenue E, Suite 310 Seattle, Washington 98102 / US | [2021/43] | Representative(s) | Merck Sharp & Dohme LLC 120 Moorgate London EC2M 6UR / GB | [N/P] |
Former [2021/43] | Böhles, Elena Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | Application number, filing date | 19898589.7 | 16.12.2019 | [2021/43] | WO2019US66444 | Priority number, date | US201862780665P | 17.12.2018 Original published format: US 201862780665 P | [2021/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020131656 | Date: | 25.06.2020 | Language: | EN | [2020/26] | Type: | A1 Application with search report | No.: | EP3897700 | Date: | 27.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.06.2020 takes the place of the publication of the European patent application. | [2021/43] | Search report(s) | International search report - published on: | US | 25.06.2020 | (Supplementary) European search report - dispatched on: | EP | 14.04.2023 | Classification | IPC: | A61K39/00, A61K39/39, C07K14/54, C12N15/86 | [2023/19] | CPC: |
A61P35/00 (EP);
A61K39/0011 (EP,US);
A61K39/39 (EP,US);
A61K45/06 (US);
C07K14/5434 (EP);
C12N15/86 (EP);
A61K2039/53 (EP);
A61K2039/55538 (EP,US);
A61K2039/585 (EP);
|
Former IPC [2021/43] | A61K39/00, A61K39/39 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/43] | Title | German: | PATHOGENASSOZIIERTE MOLEKULARE MUSTERMOLEKÜLE UND RNA-IMMUNOGENE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DER ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS | [2021/43] | English: | PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER | [2021/43] | French: | MOLÉCULES À MOTIFS MOLÉCULAIRES ASSOCIÉS À DES AGENTS PATHOGÈNES ET COMPOSITIONS IMMUNOGÈNES D'ARN ET MÉTHODES D'UTILISATION DES COMPOSITIONS POUR LE TRAITEMENT DU CANCER | [2021/43] | Entry into regional phase | 19.07.2021 | National basic fee paid | 19.07.2021 | Search fee paid | 19.07.2021 | Designation fee(s) paid | 19.07.2021 | Examination fee paid | Examination procedure | 19.07.2021 | Examination requested [2021/43] | 07.12.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 06.02.2024 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 06.02.2024 | Request for further processing filed | 06.02.2024 | Full payment received (date of receipt of payment) Request granted | 15.02.2024 | Decision despatched | Fees paid | Renewal fee | 16.12.2021 | Renewal fee patent year 03 | 09.12.2022 | Renewal fee patent year 04 | 12.12.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2009046739 (CUREVAC GMBH [DE], et al); | [XI]EP3374374 (IMMUNE DESIGN CORP [US]); | International search | [Y]US6617135 (GILLIES STEPHEN D [US], et al); | [Y]US2006226667 (LEAVERTON JOHN [US]); | [Y]US2008213318 (CLEMENTS DAVID E [US], et al); | [Y]WO2016016401 (BOEHRINGER INGELHEIM VETMED [DE]); | [Y]US2018169226 (REED STEVEN G [US], et al); |